Mental health. Special agents.
作者信息
Bryan J
机构信息
Royal Wolverhampton Trust.
出版信息
Health Serv J. 1999 Jan 28;109(5639):suppl 4-6.
PMID:10345647
Abstract
摘要
相似文献
1
Mental health. Special agents.心理健康。特工人员。
Health Serv J. 1999 Jan 28;109(5639):suppl 4-6.
2
Clozapine and hospitalization.氯氮平与住院治疗。
Psychiatr Serv. 1999 Jan;50(1):114-6. doi: 10.1176/ps.50.1.114b.
3
Economic grand rounds: systemwide costs associated with second-generation antipsychotics in the treatment of schizophrenia.经济大查房：第二代抗精神病药物治疗精神分裂症的全系统成本
Psychiatr Serv. 2004 Dec;55(12):1361-2. doi: 10.1176/appi.ps.55.12.1361.
4
Prescribing. Switching schizophrenia treatments.处方。转换精神分裂症治疗方法。
Health Serv J. 2005 Mar 31;115(5948):suppl 12.
5
Pharmaceuticals and politics.制药与政治。
Psychiatr Serv. 1995 Sep;46(9):857. doi: 10.1176/ps.46.9.857.
6
New vs. old antipsychotics: the Texas experience.新型抗精神病药物与传统抗精神病药物：德克萨斯州的经验
J Clin Psychiatry. 1999;60 Suppl 1:23-5; discussion 28-30.
7
Comparison of sole nurse and team-delivered community clozapine services for people with treatment-resistant schizophrenia.针对难治性精神分裂症患者的单人护士与团队提供社区氯氮平服务的比较。
J Adv Nurs. 2015 Mar;71(3):547-58. doi: 10.1111/jan.12527. Epub 2014 Nov 6.
8
Clozapine's cost effectiveness.氯氮平的成本效益。
Am J Psychiatry. 1995 Jan;152(1):151-2; author reply 153-4.
9
Interpretation of analysis.分析解读
Can J Clin Pharmacol. 2002 Fall;9(3):129, 153; author reply 153.
10
Atypical antipsychotic agents in the treatment of Schizophrenia and other psychiatric disorders. Part II: Special considerations.非典型抗精神病药物在精神分裂症及其他精神障碍治疗中的应用。第二部分：特殊考量。
J Clin Psychiatry. 1998 Jun;59(6):322-8. doi: 10.4088/jcp.v59n0610.
Zotero 插件